| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.029 | 0.9 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.026 | 0.9 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |